Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Principal Accounting Officer sold 14,070 shares at $2.77 ($38,974)
  6. 4 Open-market sale Director sold 139,858 shares at $2.77 ($387,407)
  7. 4 Open-market sale President & CMO sold 27,629 shares at $2.77 ($76,532)
  8. 4 Open-market sale Chief Commercial Officer sold 20,854 shares at $2.77 ($57,766)
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Material agreement · Other events
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 68 · 1,358 filings